Klinische Studie

REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness

NCT: NCT07792252 · NOT_YET_RECRUITING

NCT-IDNCT07792252

Medizinische Daten: StatusNOT_YET_RECRUITING

SponsorYale University (OTHER)

First posted2026-08-28

Last updated2026-09-09

Kurzzusammenfassung

Rejoyn is a Prescription Digital Therapeutic (PDT) for adults with Major Depressive Disorder (MDD). This study aims to evaluate the feasibility, engagement, and clinical context of integrating Rejoyn into standard interventional workflows at the Yale New Haven Hospital Interventional Psychiatry Service (IPS). This is a non-significant risk, observational real-world evidence (RWE) study.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.